Earnings calls

Meghmani Organi. concall ledger

Every earnings call for MOL — management tone, guidance, KPIs and promise tracking, quarter by quarter.

MOL · 4 transcripts · Chemicals · latest Q3 FY26

Q3 FY26Published 02 Feb 2026Call held 02 Feb 2026

MOL Q3 FY26 Earnings Call Transcript & Analysis

Standalone Revenue₹485 crStandalone EBITDA₹51 crStandalone EBITDA Margin10.6%Standalone PAT₹22 cr

Standalone Revenue ₹485 cr; Standalone EBITDA ₹51 cr; Standalone EBITDA Margin 10.6%. Standalone revenue stood at ₹485 crores, with PAT at ₹22 crores.

Read full transcript & analysis

Q2 FY26Published 12 Nov 2025Call held 12 Nov 2025

MOL Q2 FY26 Earnings Call Transcript & Analysis

Standalone Revenue₹558 cr+5% YoYStandalone EBITDA₹70 cr+71% YoYStandalone PAT₹43 cr

Standalone Revenue ₹558 cr (+5% YoY); Standalone EBITDA ₹70 cr (+71% YoY); Standalone PAT ₹43 cr. Standalone Revenue up 5% YoY to INR 558 crores.

Read full transcript & analysis

Q1 FY26Published 31 Jul 2025Call held 31 Jul 2025

MOL Q1 FY26 Earnings Call Transcript & Analysis

Standalone Revenue₹593 cr+44% YoYStandalone EBITDA₹81 cr+478% YoYStandalone PAT₹40 cr

Standalone Revenue ₹593 cr (+44% YoY); Standalone EBITDA ₹81 cr (+478% YoY); Standalone PAT ₹40 cr. Standalone revenue grew 44% YoY to ₹593 crores.

Read full transcript & analysis

Q4 FY25Published 12 May 2025Call held 12 May 2025

MOL Q4 FY25 Earnings Call Transcript & Analysis

FY25 Revenue₹2,000 cr+30% YoYFY25 EBITDA₹180 cr+1795% YoYFY25 PAT₹66 cr

FY25 Revenue ₹2,000 cr (+30% YoY); FY25 EBITDA ₹180 cr (+1795% YoY); FY25 PAT ₹66 cr. Q4 FY25 standalone revenue up 26% YoY to ~INR 500 crores.

Read full transcript & analysis